CMRA Company Description

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform.

Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions.

The company’s lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.

Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Comera Life Sciences Holdings, Inc.

Country	United States
Founded	2014
Industry	Biotechnology
Sector	Healthcare
Employees	13
CEO	Michael Campbell

Contact Details

Address: 12 Gill Street Woburn, Delaware 01801 United States
Phone	617 871 2101
Website	comeralifesciences.com

Stock Details

Ticker Symbol	CMRA
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US20037C1080
SIC Code	2836

Key Executives

Name	Position
Michael G. Campbell CPA	Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
Dr. David Soane Ph.D.	Co-Founder and Member of Scientific Advisory Board
Janice Marie McCourt B.S., CLP, M.B.A., R.Ph.	Chief Business Officer